Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study

lightmyfire2

Sep 24, 2021 09:35AM

golfyeti

Rank: Vice President [?]

Points: 24483 [?]

Votes: 217 Score: 3.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study

in response to

Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study

lightmyfire2

posted on Sep 24, 2021 10:03AM

Without getting into too many off-topic details, what is Zenith giving up to Newsora for their involvement?

And why is Zenith securing partners but not Resverlogix?

4 Recommendations

Re: Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study

fuzzyjr

Sep 24, 2021 10:19AM

Re: Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study